![N-[4-[[6-Methoxy-7-[3-(4-morpholinyl)propoxy]-4-quinazolinyl]amino]phenyl]benzamide structure, CAS 331771-20-1](/structures/60000/56622_1_331771_20_1.png)
CAS Number331771-20-1
SynonymsZM 447439; N-[4-({6-Methoxy-7-[3-(4-morpholinyl)propoxy]-4-quinazolinyl}amino)phenyl]benzamide; TCMDC-125873; ZM-447439; N-[4-({6-Methoxy-7-[3-(morpholin-4-yl)propoxy]quinazolin-4-yl}amino)phenyl]benzamide; ZM447439
Molecular FormulaC29H31N5O4
Molecular Weight513.59
Purity≥95 (HPLC)%
Density1.3±0.1 g/cm3
Boiling Point639.7±55.0 °C at 760 mmHg
Melting Point117-120ºC
Appearancesolid
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 331771-20-1 |
| Catalog No. | 2A-9056622 |
| Chinese Name | N-[4-[[6-甲氧基-7-[3-(4-吗啉基)丙氧基]-4-喹唑啉基]氨基]苯基]苯甲酰胺 |
| Synonyms | ZM 447439; N-[4-({6-Methoxy-7-[3-(4-morpholinyl)propoxy]-4-quinazolinyl}amino)phenyl]benzamide; TCMDC-125873; ZM-447439; N-[4-({6-Methoxy-7-[3-(morpholin-4-yl)propoxy]quinazolin-4-yl}amino)phenyl]benzamide; ZM447439 |
| Molecular Formula | C29H31N5O4 |
| Molecular Weight | 513.59 |
| Purity | ≥95 (HPLC) |
| Density | 1.3±0.1 g/cm3 |
| Boiling Point | 639.7±55.0 °C at 760 mmHg |
| Melting Point | 117-120ºC |
| Appearance | solid |
| Storage Condition | Desiccate at RT |
| Application | ZM-447439 is an aurora kinase (aurora) inhibitor with IC50 values of 110 and 130 nM for aurora A and B respectively. |
| MDL Number | MFCD08703125 |
| SMILES | O=C(C1=CC=CC=C1)NC(C=C2)=CC=C2NC3=NC=NC4=C3C=C(OC)C(OCCCN5CCOCC5)=C4 |
| InChI | 1S/C29H31N5O4/c1-36-26-18-24-25(19-27(26)38-15-5-12-34-13-16-37-17-14-34)30-20-31-28(24)32-22-8-10-23(11-9-22)33-29(35)21-6-3-2-4-7-21/h2-4,6-11,18-20H,5,12-17H2,1H3,(H,33,35)(H,30,31,32) |
| InChI Key | OGNYUTNQZVRGMN-UHFFFAOYSA-N |
| NACRES Code | NA.77 |
| UNSPSC | 12352200 |
| MSDS | msds/56622_1_331771_20_1.pdf |
| Transport Info | Product name: ZM-447439 |
| Related Products in Pharmaceutical Intermediates | ||
|---|---|---|
| (4R,5R)-(-)-2,2-Dimethyl-alpha,alpha,alpha',alpha'-tetraphenyl-1,3-dioxolane-4,5-dimethanolato[1,2-bis(dimethoxy)ethane]titanium (IV) dichloride | 328123-04-2 | 2A-9056589 |
| (R)-1-N-Cbz-3-cyanopyrrolidine | 329012-80-8 | 2A-9056598 |
| Boc-(R)-3-Amino-3-(4-hydroxyphenyl)propionic acid | 329013-12-9 | 2A-9056599 |
| Dichloro[(S)-(-)-2,2'-bis(diphenylphosphino)-1,1'-binaphthyl][(1R,2R)-(+)-1,2-diphenylethylenediamine]ruthenium(II) | 329735-87-7 | 2A-9056607 |
| (R)-1-(2,6-Dichloro-3-fluorophenyl)ethanol | 330156-50-8 | 2A-9056612 |
| 5,6,7,8-Tetrahydro-1,8-naphthyridine-2-methanamine | 332883-10-0 | 2A-9056630 |
| (R)-N-Methyl-1-[3,5-bis(trifluoromethyl)phenyl]ethylamine | 334477-60-0 | 2A-9056640 |
| (S)-3-Aminopiperidine dihydrochloride | 334618-07-4 | 2A-9056641 |
| (R)-3-Aminopiperidine dihydrochloride | 334618-23-4 | 2A-9056642 |
| (2S,5S)-N-Boc-5-methylpyrrolidine-2-carboxylic acid | 334769-80-1 | 2A-9056645 |
| Browse all Pharmaceutical Intermediates products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA